Maxigen Biotech Co. Ltd. of Taoyuan at MEDICA 2019 in Düsseldorf -- COMPAMED Trade Fair
Manage stand orders
Select Option

Maxigen Biotech Co. Ltd.

No. 88, Keji 1st Rd., Guishan District, 333 Taoyuan
Telephone +886 3 3287222

This company is co-exhibitor of
TAITRA Taiwan External Trade Development Council

Hall map

MEDICA 2019 hall map (Hall 6): stand H69

Fairground map

MEDICA 2019 fairground map: Hall 6

Our range of products

Product categories

  • 01  Electromedical Equipment / Medical Technology
  • 01.05  Implants and protheses
  • 01.05.03  Orthopaedic implants and prostheses

Our products

Product category: Orthopaedic implants and prostheses

Skin Care Division

By utilizing our biomedical R&D capabilities, MBI's skincare division has developed various cosmeceutical products. With our unique formulation, we dedicated to provide different kinds of efficient and reliable skincare products to meet customer's requirements for different skin types.

The quality system of MBI's skincare production facility not only meets international standards, but also become the first skincare products manufacturer in Taiwan to receive Voluntary Cosmetic GMP (ISO 22716 equivalent) certification. MBI's skincare product categories including mask series, facial cleansing series, body care series. Our skincare products and masks are distributed throughout global market under various internationally renowned labels. Recently, MBI's has developed an assortment of advanced skincare products under our own labels, using our own proprietary technology in respond to the rising demand and specific needs from our current customers and potential purchasers.

More Less

Product category: Orthopaedic implants and prostheses

Biomedical Division

Due to the growing medical demand initiated by the aging population and sedentary life style, MBI’s biomedical division has utilized its core competence in biopolymers, such as collagen and hyaluronic acid, and developed a broad range of medical devices for orthopedic, ophthalmic, dental and surgical applications. Our biomedical products have received market approval and certification for Taiwan, China, USA, Europe, Southeast Asia, Middle East and other emerging markets. In addition, our orthopedic product, Formagraft®, has been acquired by Nasdaq-listed medical device company – NuVasive Inc. in 2007. NuVasive also made equity investment in MBI in the same year and became one of our strategic partners. MBI's Biomedical facility is certified by Taiwan GMP/ISO13485/Korean KGMP and has also passed FDA inspection in 2009 and 2015.

More Less

Product category: Orthopaedic implants and prostheses

Crystal Fiber Mask

The new generation bio-cellulose mask. Thinner, better fitting, better air permeability to provide ease and comfort.

More Less

Product category: Orthopaedic implants and prostheses

Face & Neck

Single Whole Face Mask, Two-Piece Whole Face Mask, T-zone Mask, Cheek Mask, Eye Bag Mask, Eyeshade Mask, Butterfly-shaped Eye Mask, Neck Mask

More Less

About us

Company details

Company Profile

Maxigen Biotech Inc. (MBI) was founded in December 1998. Next year, MBI stationed in National Yang-Ming University and set up an incubation center at there to conduct the R&D work of collagen. In June,2002, Global Investment Holdings made capital investment for MBI and became one of the shareholders. In the Decemeber of same year, MBI started building its own biomedical factory office building at Wugu industrial park. Next year, MBI set up the skin care product facility in Sigang township, Tainan county. MBI utilizes its core competence in biopolymers and has developed a broad range of applications in areas such as medical devices and skincare products. MBI specializes in the developing, manufacturing, and marketing of biomedical and skincare products. Headquarters was moved to Hwa-Ya Technologypark in July, 2016. Our major shareholders include GIH Group, Mega International Commercial Bank, First Financial Holding, Shanghai Fuson Pharmaceutical Group Company and – NuVasive Inc., Nasdaq-listed medical device company in the US.

MBI's Biomedical facility is certified by Taiwan GMP, ISO13485 and Korean KGMP. Furthermore, it passed US FDA inspection in 2009 and 2015 with no significant deviation being observed. MBI's biomedical products are mainly applied to the usage of orthopedics, aesthetic medicine, dental and ophthalmology. Production quality is in accordance with international regulations and requirements. Also our products have been certified by Taiwan, China, USA, Europe, Southeast Asia, Middle East and other emerging markets.

MBI's Skincare Product Division specializes in the design of various types of unique formulations and it has an ISO 22716 and GMP certified manufacturing facility. Skincare division provides the most effective and reliable cosmetic products to meet the needs of various skin types. We OEM for many well known global brands as well as Taiwan domestic ones.These products including various kinds of mask series, cleansing series, skin care series, hair care series and body care series. These Products are well received and marketed all over the world.

Benefit from the core competence of biotech division, skin care R&D center also has its own proprietary development capabilities, such as the development of platinum, gold particles conductive technology raw materials "double gold crystal peptide". This is combined with our own proprietary manufacturing know-how of collagen and hyaluronic acid, therefore we are capable of developing anti-aging wrinkle, low sensitivity, moisturizing, whitening and other innovative products series for the skin regeneration and repair with more efficacy. In addition, MBI also works closely with the internationally well-known institutions then to introduce new technology collaboration and commercialization, to make the skin young, elastic again

More Less